These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 10860730)

  • 61. Orientation of the Ig domains of CD8 alpha beta relative to MHC class I.
    Devine L; Sun J; Barr MR; Kavathas PB
    J Immunol; 1999 Jan; 162(2):846-51. PubMed ID: 9916707
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The X-ray crystal structure of a Valpha2.6Jalpha38 mouse T cell receptor domain at 2.5 A resolution: alternate modes of dimerization and crystal packing.
    Plaksin D; Chacko S; Navaza J; Margulies DH; Padlan EA
    J Mol Biol; 1999 Jun; 289(5):1153-61. PubMed ID: 10373358
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of IFN-gamma receptor binding sites for JAK2 and enhancement of binding by IFN-gamma and its C-terminal peptide IFN-gamma(95-133).
    Szente BE; Subramaniam PS; Johnson HM
    J Immunol; 1995 Dec; 155(12):5617-22. PubMed ID: 7499845
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.
    Knoechel TR; Tucker AD; Robinson CM; Phillips C; Taylor W; Bungay PJ; Kasten SA; Roche TE; Brown DG
    Biochemistry; 2006 Jan; 45(2):402-15. PubMed ID: 16401071
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Allosteric activation of a spring-loaded natriuretic peptide receptor dimer by hormone.
    He Xl ; Chow Dc ; Martick MM; Garcia KC
    Science; 2001 Aug; 293(5535):1657-62. PubMed ID: 11533490
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The N-terminus and C-terminus of IFN-gamma are binding domains for cloned soluble IFN-gamma receptor.
    Griggs ND; Jarpe MA; Pace JL; Russell SW; Johnson HM
    J Immunol; 1992 Jul; 149(2):517-20. PubMed ID: 1385606
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of the C-terminal chain in human interferongamma stability: an electrostatic study.
    Altobelli G; Nacheva G; Todorova K; Ivanov I; Karshikoff A
    Proteins; 2001 May; 43(2):125-33. PubMed ID: 11276082
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
    Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dual conformations of a T cell receptor V alpha homodimer: implications for variability in V alpha V beta domain association.
    Li H; Lebedeva MI; Ward ES; Mariuzza RA
    J Mol Biol; 1997 Jun; 269(3):385-94. PubMed ID: 9199407
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of functional type I and type II interferon receptors.
    Pestka S
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1301-19. PubMed ID: 7705745
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor.
    Benoit P; Maguire D; Plavec I; Kocher H; Tovey M; Meyer F
    J Immunol; 1993 Feb; 150(3):707-16. PubMed ID: 8423335
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Unrestricted agonist activity on murine and human cells of a lipopeptide derived from IFN-gamma.
    Thiam K; Loing E; Delanoye A; Diesis E; Gras-Masse H; Auriault C; Verwaerde C
    Biochem Biophys Res Commun; 1998 Dec; 253(3):639-47. PubMed ID: 9918780
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The three-dimensional structure of a Plasmodium falciparum cyclophilin in complex with the potent anti-malarial cyclosporin A.
    Peterson MR; Hall DR; Berriman M; Nunes JA; Leonard GA; Fairlamb AH; Hunter WN
    J Mol Biol; 2000 Apr; 298(1):123-33. PubMed ID: 10756109
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of residues in the first domain of human Fc alpha receptor essential for interaction with IgA.
    Wines BD; Hulett MD; Jamieson GP; Trist HM; Spratt JM; Hogarth PM
    J Immunol; 1999 Feb; 162(4):2146-53. PubMed ID: 9973489
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Crystal structure of human class mu glutathione transferase GSTM2-2. Effects of lattice packing on conformational heterogeneity.
    Raghunathan S; Chandross RJ; Kretsinger RH; Allison TJ; Penington CJ; Rule GS
    J Mol Biol; 1994 May; 238(5):815-32. PubMed ID: 8182750
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Structure and membrane topology of the high-affinity receptor for human IFN-gamma: requirements for binding IFN-gamma. One single 90-kilodalton IFN-gamma receptor can lead to multiple cross-linked products and isolated proteins.
    Fountoulakis M; Kania M; Ozmen L; Loetscher HR; Garotta G; van Loon AP
    J Immunol; 1989 Nov; 143(10):3266-76. PubMed ID: 2530276
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Stable expression of a secreted form of the mouse IFN-gamma receptor by rat cells.
    Fernando LP; LeClaire RD; Obici S; Zavodny PJ; Russell SW; Pace JL
    J Immunol; 1991 Jul; 147(2):541-7. PubMed ID: 1830066
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of complete human IFN-gamma receptor and its extracellular domain in insect cells: purification and characterization of the recombinant proteins.
    Moosmayer D; Gerlach E; Böttinger H; Scheurich P; Pfizenmaier K
    Lymphokine Cytokine Res; 1994 Apr; 13(2):147-53. PubMed ID: 8061116
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Crystal structure of human interleukin-10 at 1.6 A resolution and a model of a complex with its soluble receptor.
    Zdanov A; Schalk-Hihi C; Wlodawer A
    Protein Sci; 1996 Oct; 5(10):1955-62. PubMed ID: 8897595
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Structural requirements for agonist activity of a murine interferon-gamma peptide.
    Szente BE; Weiner IJ; Jablonsky MJ; Krishna NR; Torres BA; Johnson HM
    J Interferon Cytokine Res; 1996 Oct; 16(10):813-7. PubMed ID: 8910766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.